Iloperidone: all 22 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled HypertensionRecruitingNCT07090161Phase 2
- Randomized Withdrawal Study in Patients With SchizophreniaRecruitingNCT06961968Phase 3
- Safety and Tolerability of Open-Labeled Iloperidone in AdolescentsRecruitingNCT05648591Phase 4
- Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I DisorderCompletedNCT04819776Phase 3Results posted
- Iloperidone in Mixed States of Bipolar DisorderCompletedNCT02413918Phase 4Results posted
- Assessing the Effects of Fanapt® on Social Cognition in SchizophreniaTerminatedNCT01929889Phase 4Results posted
- Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or PlaceboCompletedNCT01920802Phase 4Results posted
- Iloperidone for Symptoms of Arousal in Post Traumatic Stress Disorder (PTSD)TerminatedNCT01917318Phase 2Results posted
- Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and IrritabilityCompletedNCT01464229Phase 4Results posted
- Relapse Prevention Study in Patients With SchizophreniaCompletedNCT01291511Phase 3Results posted
- Switching to Iloperidone From Other Antipsychotics in SchizophreniaCompletedNCT01207414Phase 4Results posted
- Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute SchizophreniaCompletedNCT00254202Phase 3Results posted
- Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State ConditionsCompletedNCT06494397Phase 1
- A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease PsychosisWithdrawnNCT05344365Phase 2
- Bioequivalence Study Between VHX-896 Tablets and Iloperidone Tablets in Healthy VolunteersCompletedNCT04969211Phase 1
- A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of SchizophreniaCompletedNCT04712734Phase 1
- Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or SchizophreniaCompletedNCT04127058Phase 1
- Human Bioequivalence Test (Fasting & Postprandial) of Iloperidone TabletsStatus unknownNCT03420534Phase 1
- Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With SchizophreniaStatus unknownNCT02453893Phase 3
- Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat SchizophreniaCompletedNCT01623713Phase 2
- Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy VolunteersCompletedNCT01529294Phase 1
- Tolerability and Pharmacokinetics of Iloperidone in Adolescent PatientsCompletedNCT01495169Phase 1